BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27565913)

  • 41. Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer.
    Tang T; Yang C; Brown HE; Huang J
    Dis Markers; 2018; 2018():6184162. PubMed ID: 30245753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Strategy to Investigate Tissue-Secreted Tumor Microenvironmental Proteins in Serum toward Development of Breast Cancer Early Diagnosis Biomarker Signature.
    Pendharkar N; Dhali S; Abhang S
    Proteomics Clin Appl; 2019 May; 13(3):e1700119. PubMed ID: 30281209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
    Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer.
    Du J; Yang S; Lin X; Bu L; Nan Y; Huo S; Shang W
    Diagn Pathol; 2010 Sep; 5():60. PubMed ID: 20854674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
    Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
    Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
    Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
    Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Serum 4-microRNA Signature for Lung Cancer Detection.
    Nadal E; Truini A; Nakata A; Lin J; Reddy RM; Chang AC; Ramnath N; Gotoh N; Beer DG; Chen G
    Sci Rep; 2015 Jul; 5():12464. PubMed ID: 26202143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules.
    Pecot CV; Li M; Zhang XJ; Rajanbabu R; Calitri C; Bungum A; Jett JR; Putnam JB; Callaway-Lane C; Deppen S; Grogan EL; Carbone DP; Worrell JA; Moons KG; Shyr Y; Massion PP
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):786-92. PubMed ID: 22374995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
    Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic strategies for the characterization and the early detection of lung cancer.
    Massion PP; Caprioli RM
    J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic Screening for Serum Biomarkers for Cervical Cancer and Their Clinical Significance.
    Chen Y; Xiong X; Wang Y; Zhao J; Shi H; Zhang H; Wang Y; Wei Y; Xue W; Zhang J
    Med Sci Monit; 2019 Jan; 25():288-297. PubMed ID: 30625128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction and Validation of a Lung Cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers.
    Kang C; Wang D; Zhang X; Wang L; Wang F; Chen J
    Comput Math Methods Med; 2021; 2021():9987067. PubMed ID: 34257703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer.
    Klupczynska A; Swiatly A; Hajduk J; Matysiak J; Dyszkiewicz W; Pawlak K; Kokot ZJ
    Int J Mol Sci; 2016 Mar; 17(4):410. PubMed ID: 27043541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer.
    Zhang L; Pu D; Liu D; Wang Y; Luo W; Tang H; Huang Y; Li W
    Lung Cancer; 2019 Sep; 135():130-137. PubMed ID: 31446985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.
    Guergova-Kuras M; Kurucz I; Hempel W; Tardieu N; Kádas J; Malderez-Bloes C; Jullien A; Kieffer Y; Hincapie M; Guttman A; Csánky E; Dezso B; Karger BL; Takács L
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.010298. PubMed ID: 21947365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer.
    Alegre MM; Weyant MJ; Bennett DT; Yu JA; Ramsden MK; Elnaggar A; Robison RA; O'Neill KL
    Anticancer Res; 2014 May; 34(5):2145-51. PubMed ID: 24778016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.